Cardinal Health (NYSE:CAH) shares reached a new 52-week high, trading as high as $240.93 with a volume of over 1.9 million shares. The stock recently closed at $237.92, reflecting continued investor interest despite mixed analyst sentiment regarding the company's recent performance and future outlook. In...
Cardinal Health (CAH) recently reported an 11% year-over-year revenue increase and raised its fiscal 2026 non-GAAP earnings per share (EPS) guidance. These developments have coincided with stronger demand for high-margin specialty drugs, driving renewed investor attention to the stock. The positive momentum is reflected in...
Cardinal Health's Disposable Instant Cold Pack is a single-use medical accessory designed for clinics, athletic trainers, and home users requiring immediate cold therapy without refrigeration. The product utilizes an endothermic reaction involving ammonium nitrate to generate cold within seconds of activation, offering a practical solution...
Cardinal Health (CAH) recently traded at $212.79 per share, reflecting a 4.1% gain during the evening session and a year-over-year return of 33.6%, outperforming the S&P 500 by 10.9%. The company operates as a healthcare services and products provider with over 53,000 employees, offering a...
Cardinal Health (CAH) shares have outperformed the broader market and industry peers, losing only 2.5% year-to-date compared to a 9.3% decline in the healthcare industry and an 8.1% rise in the S&P 500. The company reported strong fiscal third-quarter results driven by robust demand in...
Cardinal Health is positioning itself as a foundational element of the U.S. healthcare infrastructure by leveraging its scale and operational reliability across pharmaceutical distribution, specialty care, and advanced logistics. The company's Pharmaceutical & Specialty Solutions segment contributed approximately $61 billion to quarterly revenues, supporting tens...
Cardinal Health Inc. (CAH) recently announced a strategic combination of financial improvements, raising its quarterly dividend and lifting fiscal 2026 earnings guidance in early May 2026. This move signals management's confidence in the momentum within its specialty pharmaceutical business and core distribution operations. The company...
The article evaluates Cardinal Health (CAH) and UnitedHealth Group (UNH) over a 12-month period starting May 29, 2025, comparing their performance against an earlier prediction that favored Cardinal Health. Although Cardinal Health was the initial recommendation, UnitedHealth outperformed in terms of total return, rising from...
Cardinal Health, Inc. (CAH) presented at the Bank of America Global Healthcare Conference on May 13, 2026, with CFO Aaron Alt and VP of Investor Relations Dave Frost discussing recent performance and strategic outlook. During the opening remarks, Alt highlighted that the company had recently...
JPMorgan Chase recently raised its price target on Cardinal Health (NYSE:CAH) to $215 per share, reflecting continued analyst interest in the healthcare distributor's fundamentals. The article contextualizes this bullish rating against a backdrop of recent stock volatility, noting that CAH shares actually saw a 7.8%...
Cardinal Health, Inc. (CAH) is highlighted as a potential value investment opportunity, currently holding a Zacks Rank of #2 (Buy) and an "A" grade in the Value category according to Zacks Investment Research's Style Scores system. The article notes that Cardinal Health trades with a...
Cardinal Health, Inc. (NYSE:CAH) is featured in an article titled "5 Best Fortune 500 Stocks to Buy According to Analysts," which highlights recent positive sentiment and financial performance from the medical distribution giant. On May 1, TD Cowen analyst firm increased its price target for...
Cardinal Health (CAH) has experienced a recent downtrend, losing 8.8% over the past two weeks, but technical analysis suggests a potential reversal following the formation of a hammer chart pattern on its last trading session. This candlestick pattern indicates that while the stock opened lower...
Jim Cramer's Charitable Trust is increasing its holdings in Cardinal Health (CAH) by purchasing 50 shares at approximately $199 per share. This transaction brings the trust's total ownership to 525 shares, raising the position's weight in the portfolio from 2.50% to 2.75%. The team is...
Kevin Stankiewicz from the Investing Club argues that Cardinal Health's (CAH) significant sell-off on Thursday was an overreaction and expresses a strong desire to buy shares if not restricted by CNBC trading rules. The author notes that Jim Cramer mentioned the stock on CNBC TV...
Cardinal Health, Inc. reported third-quarter fiscal 2026 results that exceeded analyst expectations for earnings per share but fell short on revenue. The company's adjusted EPS reached $3.17, surpassing the Zacks Consensus Estimate of $2.80 by 13.2%, while GAAP EPS stood at $1.69 compared to $2.10...
Cardinal Health (CAH) reported Q3 earnings per share of $3.17, surpassing the Zacks Consensus Estimate of $2.80 and significantly exceeding the year-ago figure of $2.35. The quarterly results reflect a positive earnings surprise of 13.22%, continuing a streak where the company has beaten consensus EPS...
Shares of Cardinal Health (CAH) fell more than 6% on Thursday following the release of mixed quarterly results for the period ending March 31. While revenue grew 11% year over year to $60.94 billion, it missed analyst expectations of $61.7 billion across all three operating...
Cardinal Health reported its third quarter fiscal year 2026 results with total revenues reaching $60.9 billion, representing an 11% increase compared to the same period in fiscal year 2025. While GAAP diluted earnings per share dropped 20% to $1.69 and operating earnings fell 30% to...
Cardinal Health Inc. (CAH) reported fiscal third-quarter earnings of $399 million, translating to a profit of $1.69 per share for the company headquartered in Dublin, Ohio. When adjusting for specific factors such as asset impairment costs and merger-related expenses, the adjusted earnings increased to $3.17...
